tailieunhanh - Lapatinib in combination with capecitabine versus continued use of trastuzumab in breast cancer patients with trastuzumabresistance: A retrospective study of a Chinese population

The efficacy and safety of lapatinib plus capecitabine (LC or LX) versus trastuzumab plus chemotherapy in patients with HER-positive metastatic breast cancer who are resistant to trastuzumab is unknown. | Lapatinib in combination with capecitabine versus continued use of trastuzumab in breast cancer patients with trastuzumabresistance A retrospective study of a Chinese population

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN